Blog

Oncology Labs Are Missing Actionable Tumor Mutations. Somatic Variant Calling Is the Gap No One Is Talking About

Disha Vyas — Tue, 23 Jun 2026 04:00:00 GMT

Tumor sequencing has never been more accessible. Sequencing costs have dropped, throughput has increased, and most oncology labs can generate millions of reads from a single experiment. Yet clinically relevant mutations are still being missed not because of sequencing failure, but because detecting low-frequency somatic variants is a fundamentally different problem from generating high-quality data.

Demystifying Immunomics: A Researcher's Guide to TCR and BCR Repertoire Profiling

Disha Vyas — Mon, 15 Jun 2026 04:00:00 GMT

A researcher dedicates months to carefully design experiments to probe immune responses. Now, terabytes of raw sequencing data are waiting to be analyzed. The goal of identifying specific phenotypes or tracking immune cell dynamics is challenging, and the computational analysis required to extract these insights can feel tricky.

Hundreds of Variants, Zero Diagnosis: Why Trio Exome Sequencing Is Changing Rare Disease Research

Disha Vyas — Tue, 09 Jun 2026 04:00:00 GMT

You've got a patient with a constellation of baffling symptoms, a family history riddled with question marks, and a growing sense of urgency. Standard genetic testing has come up empty, leaving you sifting through mountains of inconclusive data. The clock is ticking, and the pressure to find answers is mounting. Could trio exome sequencing be the breakthrough you need?

RNA-Seq Data Is Piling Up in Regional Labs – And Most of It Never Gets Properly Analyzed

Disha Vyas — Thu, 04 Jun 2026 04:00:00 GMT

Research Hospitals Are Adopting Whole Exome Sequencing – Yet Their Reports Are Missing The Point

Disha Vyas — Mon, 01 Jun 2026 04:00:00 GMT

Next-Generation Sequencing (NGS) hardware is moving incredibly fast. Across the medical sector, research hospitals and clinical laboratories have aggressively upgraded their machines. Driven by new diagnostic guidelines for rare anomalies and developmental delays, Whole Exome Sequencing (WES) has officially gone mainstream.

Malaria’s Genetic Evolution: A Growing Global Challenge

Disha Vyas — Sat, 25 Apr 2026 04:00:00 GMT

Malaria is often seen as a long-standing disease we already understand. But in reality, it is constantly evolving at the genetic level. In 2024 alone, malaria caused an estimated 282 million cases and over 600,000 deaths worldwide, highlighting its continued global impact.

Key to the Biological Lock: DNA Structure to Genomics

Disha Vyas — Fri, 24 Apr 2026 04:00:00 GMT

Inside every cell lies a code compact, precise, and incredibly powerful. DNA (Deoxyribonucleic Acid) is the fundamental molecule of life, carrying genetic instructions that define how organisms grow, function, and evolve.

Earth Day 2026: There Is No Plan(et) B

Yashasvi Adhikari — Wed, 22 Apr 2026 04:00:00 GMT

Earth Day 2026 highlights how environmental awareness has evolved into meaningful action. What began as a movement is now a global effort to protect the planet through sustainability, research, and collective responsibility.

Tuberculosis: Deadly Blind Spot of Modern Medicine

Yashasvi Adhikari — Tue, 24 Mar 2026 04:00:00 GMT

Down Syndrome: Overcoming Biological Barriers With Science and Empathy

Yashasvi Adhikari — Fri, 20 Mar 2026 04:00:00 GMT

" Children with Down syndrome have an extraordinary sweetness of temperament, as if in inheriting an extra chromosome they had acquired a concomitant loss of cruelty and malice."
- Siddhartha Mukherjee, The Gene: An Intimate History